|
US2802005A
(en)
|
|
1957-08-06 |
|
S-eluorourace |
|
US2331725A
(en)
|
1941-01-31 |
1943-10-12 |
Lederle Lab Inc |
Preparation of 2-methyl-1,4-naphthoquinone
|
|
US3205220A
(en)
|
1961-10-26 |
1965-09-07 |
Lilly Co Eli |
Leurosidine and leurocristine and their production
|
|
CH514578A
(de)
|
1968-02-27 |
1971-10-31 |
Sandoz Ag |
Verfahren zur Herstellung von Glucosiden
|
|
GB1457632A
(en)
|
1974-03-22 |
1976-12-08 |
Farmaceutici Italia |
Adriamycins
|
|
DD159877A1
(de)
|
1981-06-12 |
1983-04-13 |
Wolfgang Krueger |
Verfahren zur herstellung von 4-[1-methyl-5-bis(2-chloraethyl)amino-benzimidazolyl-2]-buttersaeure
|
|
OA07174A
(fr)
|
1981-08-24 |
1984-04-30 |
May & Baker Ltd |
Nouvelles imidazotétrazionones, leur préparation et les médicaments qui les contiennent.
|
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
|
ES8604088A1
(es)
|
1985-06-14 |
1986-01-16 |
Espanola Farma Therapeut |
Procedimiento para la obtencion de un compuesto derivado de un acido dicarboxilico
|
|
FR2601676B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Procede de preparation du taxol et du desacetyl-10 taxol
|
|
FR2601675B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5004758A
(en)
|
1987-12-01 |
1991-04-02 |
Smithkline Beecham Corporation |
Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
|
|
IL96531A
(en)
|
1989-12-11 |
1995-08-31 |
Univ Princeton |
History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
|
|
US5369108A
(en)
|
1991-10-04 |
1994-11-29 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
|
WO1994006802A1
(fr)
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienodiazepine et son utilisation medicinale
|
|
TW438775B
(en)
|
1995-04-07 |
2001-06-07 |
Pharmacia & Upjohn Co Llc |
Novel intermediates and process for the manufacture of camptothecin derivatives (CPT-11) and related compounds
|
|
US6174905B1
(en)
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
JP3354090B2
(ja)
|
1996-09-30 |
2002-12-09 |
シエーリング アクチエンゲゼルシャフト |
分化誘導剤
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
GB0108591D0
(en)
|
2001-04-05 |
2001-05-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US7425553B2
(en)
|
2003-05-30 |
2008-09-16 |
Gemin X Pharmaceuticals Canada Inc. |
Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
|
|
WO2005049593A2
(en)
|
2003-11-13 |
2005-06-02 |
Abbott Laboratories |
N-acylsulfonamide apoptosis promoters
|
|
ATE399155T1
(de)
|
2004-03-23 |
2008-07-15 |
Pfizer Prod Inc |
Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
|
|
US7893278B2
(en)
|
2004-06-17 |
2011-02-22 |
Hoffman-La Roche Inc. |
CIS-imidazolines
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
US8557812B2
(en)
|
2004-08-20 |
2013-10-15 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof
|
|
KR20200019263A
(ko)
|
2004-09-02 |
2020-02-21 |
제넨테크, 인크. |
헤지호그 신호전달에 대한 피리딜 억제제
|
|
EP1833981B1
(en)
|
2004-12-16 |
2012-04-18 |
President and Fellows of Harvard College |
Histone demethylation mediated by the nuclear amine oxidase homolog lsd1
|
|
DK1704859T3
(da)
|
2005-02-18 |
2010-11-22 |
Universitaetsklinikum Freiburg |
Kontrol af androgen receptor-afhængig genenkspression ved inhibering af amin-oxidase-aktiviteten af lysin-specifik demetylase (LSD1)
|
|
HRP20100678T1
(hr)
|
2005-03-29 |
2011-02-28 |
Icos Corporation |
Derivati heteroariluree korisni kao inhibitori chk1
|
|
TWI375673B
(en)
|
2005-04-11 |
2012-11-01 |
Abbott Lab |
1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
|
|
EP2757099B1
(en)
|
2005-05-12 |
2017-08-23 |
AbbVie Bahamas Limited |
Apoptosis promoters
|
|
WO2007015632A1
(en)
|
2005-08-04 |
2007-02-08 |
Cgk Co., Ltd. |
Atm and atr inhibitor
|
|
KR20080088570A
(ko)
|
2005-08-10 |
2008-10-02 |
더 존스 홉킨스 유니버시티 |
항기생충 및 항암 치료제 및 라이신-특이적인 디메틸라제억제제로 유용한 폴리아민
|
|
NL2000613C2
(nl)
|
2006-05-11 |
2007-11-20 |
Pfizer Prod Inc |
Triazoolpyrazinederivaten.
|
|
CL2007003244A1
(es)
|
2006-11-16 |
2008-04-04 |
Millennium Pharm Inc |
Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
|
|
EP2142287A4
(en)
|
2007-04-13 |
2012-05-23 |
Univ Johns Hopkins |
INHIBITORS OF LYSINPECIFIC DEMETHYLASE
|
|
CA2700173C
(en)
|
2007-09-25 |
2016-10-11 |
Topotarget Uk Limited |
Methods of synthesis of certain hydroxamic acid compounds
|
|
KR20110025178A
(ko)
|
2008-05-16 |
2011-03-09 |
파르마 마르 에스.에이. |
Ｐｍ00104 및 다른 항종양제를 이용한 복합 치료법
|
|
EP2317992A2
(en)
|
2008-07-24 |
2011-05-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Preventing or treating viral infection using an inhibitor of the lsd1 protein, a mao inhibitor or an inhibitor of lsd1 and a mao inhibitor
|
|
JO2889B1
(en)
|
2008-09-17 |
2015-03-15 |
نوفارتيس ايه جي |
Salts 6N - (CIS-2, 6-dimethyl morpholine-4-yl) pyridine-3-yl-methyl-4 ’- (tetrafluoromethoxy) [1,1,-2-phenyl] -3-carboxamide
|
|
WO2010043721A1
(en)
|
2008-10-17 |
2010-04-22 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
US8993808B2
(en)
|
2009-01-21 |
2015-03-31 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
CA2929347A1
(en)
|
2009-05-26 |
2010-12-02 |
Milan Bruncko |
(hetero)aryl substituted sulfonyl-2-(1h-pyrrolo[2,3-b]pyridine-5-oxy)benzamide compounds and their use as apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
US8389580B2
(en)
|
2009-06-02 |
2013-03-05 |
Duke University |
Arylcyclopropylamines and methods of use
|
|
EP2258865A1
(en)
|
2009-06-05 |
2010-12-08 |
Universitätsklinikum Freiburg |
Lysine-specific demethylase 1 (LSD1) is a biomarker for breast cancer
|
|
WO2010143582A1
(ja)
|
2009-06-11 |
2010-12-16 |
公立大学法人名古屋市立大学 |
フェニルシクロプロピルアミン誘導体及びlsd1阻害剤
|
|
AR077014A1
(es)
|
2009-06-19 |
2011-07-27 |
Lilly Co Eli |
Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
|
|
US9708255B2
(en)
|
2009-08-18 |
2017-07-18 |
Robert A. Casero |
(bis)urea and (bis)thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
US8859555B2
(en)
|
2009-09-25 |
2014-10-14 |
Oryzon Genomics S.A. |
Lysine Specific Demethylase-1 inhibitors and their use
|
|
EP2486002B1
(en)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
NZ601655A
(en)
|
2010-01-22 |
2014-10-31 |
Acetylon Pharmaceuticals Inc |
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
|
|
US9616058B2
(en)
|
2010-02-24 |
2017-04-11 |
Oryzon Genomics, S.A. |
Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
|
|
WO2011106573A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
WO2011113005A2
(en)
|
2010-03-12 |
2011-09-15 |
The Johns Hopkins University |
Compositions and methods for combinations of oligoamines with 2-difluoromethylornithine (dfmo)
|
|
MX2012012111A
(es)
|
2010-04-19 |
2013-05-30 |
Oryzon Genomics Sa |
Inhibidores de demetilasa-1 especifica de lisina y su uso.
|
|
AU2011244478B2
(en)
|
2010-04-20 |
2014-07-17 |
Fondazione IEO-CCM |
Tranylcypromine derivatives as inhibitors of histone demethylase LSD1 and/or LSD2
|
|
US8536179B2
(en)
|
2010-05-07 |
2013-09-17 |
Glaxosmithkline Llc |
Indoles
|
|
WO2011140325A1
(en)
|
2010-05-07 |
2011-11-10 |
Glaxosmithkline Llc |
Indazoles
|
|
JP5913292B2
(ja)
|
2010-05-14 |
2016-04-27 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
代謝を調節する組成物および方法
|
|
SI2598482T1
(sl)
|
2010-07-29 |
2018-09-28 |
Oryzon Genomics, S.A. |
Inhibitorji demetilaze lsd1 na osnovi arilciklopropilamina in njihova medicinska uporaba
|
|
WO2012013727A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
US9527805B2
(en)
|
2010-09-10 |
2016-12-27 |
Robert A. Casero |
Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
US20130303545A1
(en)
|
2010-09-30 |
2013-11-14 |
Tamara Maes |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
WO2012045883A1
(en)
|
2010-10-08 |
2012-04-12 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
GB201112607D0
(en)
|
2011-07-22 |
2011-09-07 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
JP5931905B2
(ja)
|
2010-12-03 |
2016-06-08 |
エピザイム，インコーポレイティド |
置換プリン及び７‐デアザプリン化合物
|
|
WO2012107499A1
(en)
|
2011-02-08 |
2012-08-16 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disorders
|
|
WO2012107498A1
(en)
|
2011-02-08 |
2012-08-16 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
CA2828212A1
(en)
|
2011-02-23 |
2012-08-30 |
Shiraz Mujtaba |
Inhibitors of bromodomains as modulators of gene expression
|
|
EP3323820B1
(en)
|
2011-02-28 |
2023-05-10 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
TWI530489B
(zh)
|
2011-03-22 |
2016-04-21 |
必治妥美雅史谷比公司 |
雙（氟烷基）－１，４－苯二氮呯酮化合物
|
|
CA2831143C
(en)
|
2011-03-25 |
2019-05-21 |
Glaxosmithkline Intellectual Property Development Limited |
Cyclopropylamines as lsd1 inhibitors
|
|
JO3363B1
(ar)
|
2011-04-13 |
2019-03-13 |
Epizyme Inc |
مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
|
|
US20140296255A1
(en)
|
2011-05-19 |
2014-10-02 |
Oryzong Genomics, S.A. |
Lysine demethylase inhibitors for thrombosis and cardiovascular diseases
|
|
EP2741741A2
(en)
|
2011-05-19 |
2014-06-18 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for inflammatory diseases or conditions
|
|
AR087107A1
(es)
|
2011-07-27 |
2014-02-12 |
Lilly Co Eli |
Compuesto inhibidor de la señalizacion de la trayectoria notch
|
|
UA114406C2
(uk)
|
2011-08-09 |
2017-06-12 |
Такеда Фармасьютікал Компані Лімітед |
Похідні циклопропанаміну як інгібітори lsd1
|
|
SG2014009609A
(en)
|
2011-08-15 |
2014-05-29 |
Univ Utah Res Found |
Substituted (e)-n'-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhiitors
|
|
RS58475B1
(sr)
|
2011-10-20 |
2019-04-30 |
Oryzon Genomics Sa |
Jedinjenja (hetero)aril ciklopropilamina kao lsd1 inhibitori
|
|
CN107266345B
(zh)
|
2011-10-20 |
2021-08-17 |
奥瑞泽恩基因组学股份有限公司 |
作为lsd1抑制剂的(杂)芳基环丙胺化合物
|
|
CA2862289C
(en)
|
2012-02-10 |
2019-11-26 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
US9828344B2
(en)
|
2012-06-01 |
2017-11-28 |
LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT e.V. (FLI) |
Inhibitors of the notch signaling pathway and secretion for use in medicine
|
|
US9751885B2
(en)
|
2012-10-12 |
2017-09-05 |
Takeda Pharmaceutical Company Limited |
Cyclopropanamine compound and use thereof
|
|
EP2927212A4
(en)
|
2012-11-28 |
2016-06-08 |
Univ Kyoto |
LSD1-SELECTIVE HEMMER WITH LYSINE STRUCTURE
|
|
US9144555B2
(en)
|
2012-11-30 |
2015-09-29 |
Darlene E. McCord |
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
|
|
EP2740474A1
(en)
|
2012-12-05 |
2014-06-11 |
Instituto Europeo di Oncologia S.r.l. |
Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
|
AU2014223990A1
(en)
|
2013-02-28 |
2015-09-10 |
Washington University |
Methods of treatment of human cytomegalovirus infection and diseases with bromodomain inhibitors
|
|
WO2014164867A1
(en)
|
2013-03-11 |
2014-10-09 |
Imago Biosciences |
Kdm1a inhibitors for the treatment of disease
|
|
JP2016517434A
(ja)
|
2013-03-14 |
2016-06-16 |
エピザイム，インコーポレイティド |
癌を処置するための併用療法
|
|
US9918983B2
(en)
|
2013-05-30 |
2018-03-20 |
The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas |
Suicidal LSD1 inhibitors targeting SOX2-expressing cancer cells
|
|
KR102288648B1
(ko)
|
2013-06-19 |
2021-08-12 |
유니버시티 오브 유타 리서치 파운데이션 |
히스톤 데메틸라제 억제제로서의 치환된 (e)-n′-(1-페닐에틸리덴)벤조하이드라지드 동족체
|
|
EP2829284A1
(en)
|
2013-07-22 |
2015-01-28 |
Deutsches Krebsforschungszentrum |
Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor
|
|
AU2014306149B2
(en)
|
2013-08-06 |
2019-09-19 |
Imago Biosciences Inc. |
KDM1A inhibitors for the treatment of disease
|
|
WO2015031564A2
(en)
|
2013-08-30 |
2015-03-05 |
University Of Utah |
Substituted-1h-benzo[d]imidazole series compounds as lysine-specfic demethylase 1 (lsd1) inhibitors
|
|
EP3076977B1
(en)
|
2013-12-06 |
2021-03-03 |
Epizyme, Inc. |
Combination therapy for treating cancer
|
|
PL3080100T3
(pl)
|
2013-12-11 |
2023-03-06 |
Celgene Quanticel Research, Inc. |
Inhibitory lizyno-specyficznej demetylazy-1
|
|
US10118903B2
(en)
|
2014-02-07 |
2018-11-06 |
Musc Foundation For Research Development |
Aminotriazole-based KDM1A inhibitors as epigenetic modulators
|
|
KR102421235B1
(ko)
|
2014-02-13 |
2022-07-15 |
인사이트 코포레이션 |
Lsd1 저해제로서 사이클로프로필아민
|
|
EP3392244A1
(en)
|
2014-02-13 |
2018-10-24 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
NZ723203A
(en)
|
2014-02-13 |
2020-08-28 |
Incyte Corp |
Cyclopropylamines as lsd1 inhibitors
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
JP2017508798A
(ja)
*
|
2014-03-07 |
2017-03-30 |
ザ ジョンズ ホプキンス ユニバーシティ |
ヒストンリジン特異的デメチラーゼ（ｌｓｄ１）およびヒストンデアセチラーゼ（ｈｄａｃ）の阻害剤
|
|
SG11201608340UA
(en)
|
2014-04-11 |
2016-11-29 |
Takeda Pharmaceuticals Co |
Cyclopropanamine compound and use thereof
|
|
HUE057895T2
(hu)
|
2014-05-01 |
2022-06-28 |
Celgene Quanticel Res Inc |
Lizinspecifikus demetiláz-1 inhibitorai
|
|
AU2015265820C1
(en)
|
2014-05-30 |
2020-01-16 |
Ieo - Istituto Europeo Di Oncologia S.R.L. |
Cyclopropylamine compounds as histone demethylase inhibitors
|
|
MX376632B
(es)
|
2014-06-27 |
2025-03-07 |
Celgene Quanticel Res Inc |
Inhibidores de demetilasa-1 especifica de lisina.
|
|
EA033698B1
(ru)
|
2014-07-03 |
2019-11-18 |
Celgene Quanticel Res Inc |
Ингибиторы лизинспецифической деметилазы-1
|
|
MX391865B
(es)
|
2014-07-03 |
2025-03-21 |
Celgene Quanticel Res Inc |
Inhibidores de demetilasa-1 especifica de lisina.
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
CA2956962A1
(en)
*
|
2014-08-13 |
2016-02-18 |
Epizyme, Inc. |
Combination therapy for treating cancer
|
|
EP2993175A1
(en)
|
2014-09-05 |
2016-03-09 |
IEO - Istituto Europeo di Oncologia Srl |
Thienopyrroles as histone demethylase inhibitors
|
|
ES2935114T3
(es)
|
2014-09-05 |
2023-03-01 |
Celgene Quanticel Res Inc |
Inhibidores de la desmetilasa 1 específica de lisina
|
|
WO2016123387A1
(en)
|
2015-01-30 |
2016-08-04 |
Genentech, Inc. |
Therapeutic compounds and uses thereof
|
|
KR102626978B1
(ko)
|
2015-02-12 |
2024-01-18 |
이마고 바이오사이언시즈 인코포레이티드 |
질환 치료를 위한 kdm1a 저해제
|
|
CN106146361A
(zh)
|
2015-03-16 |
2016-11-23 |
四川大学 |
茚-1-亚基磺酰基苯甲酰肼衍生物及其制备方法和用途
|
|
UA122688C2
(uk)
|
2015-04-03 |
2020-12-28 |
Інсайт Корпорейшн |
Гетероциклічні сполуки як інгібітори lsd1
|
|
CN106045862B
(zh)
|
2015-04-10 |
2019-04-23 |
上海迪诺医药科技有限公司 |
环丙胺类螺(杂)环化合物、其药物组合物及应用
|
|
US10526287B2
(en)
|
2015-04-23 |
2020-01-07 |
Constellation Pharmaceuticals, Inc. |
LSD1 inhibitors and uses thereof
|
|
EP3090998A1
(en)
|
2015-05-06 |
2016-11-09 |
F. Hoffmann-La Roche AG |
Solid forms
|
|
AU2016275702A1
(en)
|
2015-06-12 |
2017-12-21 |
Oryzon Genomics, S.A. |
Biomarkers associated with LSD1 inhibitors and uses thereof
|
|
US20170001970A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Utah Research Foundation |
Substituted benzohydrazide analogs as histone demethylase inhibitors
|
|
WO2017013061A1
(en)
|
2015-07-17 |
2017-01-26 |
Oryzon Genomics, S.A. |
Biomarkers associated with lsd1 inhibitors and uses thereof
|
|
JP7427363B2
(ja)
|
2015-08-12 |
2024-02-05 |
インサイト・ホールディングス・コーポレイション |
Ｌｓｄ１阻害剤の塩
|
|
CN105233292B
(zh)
*
|
2015-10-19 |
2018-03-13 |
中国科学院北京基因组研究所 |
Ory‑1001联合放疗和化疗用于治疗人三阴性乳腺癌的用途
|
|
CN105541806A
(zh)
|
2015-12-25 |
2016-05-04 |
中国药科大学 |
巴比妥酸类化合物、制备方法及其应用
|
|
CN105924362B
(zh)
|
2016-02-05 |
2018-08-17 |
上海龙翔生物医药开发有限公司 |
芳香环丙基胺类化合物、其药学上可接受的盐、其制备方法及其用途
|
|
ES3057783T3
(en)
|
2016-03-15 |
2026-03-04 |
Oryzon Genomics Sa |
Combinations of lsd1 inhibitors for use in the treatment of neoplastic diseases
|
|
US11013698B2
(en)
|
2016-03-15 |
2021-05-25 |
Oryzon Genomics S.A. |
Combinations of LSD1 inhibitors for the treatment of hematological malignancies
|
|
WO2017158136A1
(en)
|
2016-03-16 |
2017-09-21 |
Oryzon Genomics, S.A. |
Methods to determine kdm1a target engagement and chemoprobes useful therefor
|
|
CN106045881B
(zh)
|
2016-05-26 |
2017-10-31 |
新乡医学院 |
一类白藜芦醇衍生物、其制备方法及作为lsd1抑制剂的应用
|